Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis: A Randomized Placebo-Controlled Trial

NCT07759557 is registered in ClinicalTrials.gov with Khon Kaen University as lead sponsor.

NCT NCT07759557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07759557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis: A Randomized Placebo-Controlled Trial
Lead sponsor
Khon Kaen University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
December 31, 2028
Enrollment
72 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

raynaud disease secondary to scleroderma, systemic sclerosis (ssc)